Most of the authors have variously received unrestricted educational grants, consultancy fees, and/or hospitality from various pharmaceutical companies in the field of inflammatory bowel disease and anemia therapy. No author was paid for this work, nor did any company contribute to the consensus statements or text.
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases†
Article first published online: 5 NOV 2007
Copyright © 2007 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 13, Issue 12, pages 1545–1553, December 2007
How to Cite
Gasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., Oldenburg, B., Rampton, D., Schroeder, O., Stein, J., Travis, S. and Van Assche, G. (2007), Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis, 13: 1545–1553. doi: 10.1002/ibd.20285
- Issue published online: 5 NOV 2007
- Article first published online: 5 NOV 2007
- Manuscript Accepted: 17 AUG 2007
- Manuscript Received: 31 JUL 2007
- inflammatory bowel diseases;
- iron deficiency;
Anemia is a common complication of inflammatory bowel diseases. An international working party has formed and developed guidelines for evaluation and treatment of anemia and iron deficiency that should serve practicing gastroenterologists. Within a total of 16 statements, recommendations are made regarding diagnostic measures to screen for iron- and other anemia-related deficiencies regarding the triggers for medical intervention, treatment goals, and appropriate therapies. Anemia is a common cause of hospitalization, prevents physicians from discharging hospitalized patients, and is one of the most frequent comorbid conditions in patients with inflammatory bowel disease. It therefore needs appropriate attention and specific care.
(Inflamm Bowel Dis 2007;13:1545–1553)